Apellis Pharmaceuticals (APLS) Debt to Equity (2014 - 2026)
Apellis Pharmaceuticals (APLS) debt to equity from Dec 31, 2014 to Mar 31, 2026. The current Apellis Pharmaceuticals (APLS) debt to equity is 22.59%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Apellis Pharmaceuticals (APLS)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 25.30% | N/A |
| 2024 | 0.00% | -100.00% |
| 2023 | 47.83% | N/A |
| 2023 | 47.83% | -12.40% |
| 2022 | 54.59% | N/A |
| 2022 | 0.00% | N/A |
| 2021 | 0.00% | N/A |
| 2021 | 0.00% | N/A |
| 2020 | 0.00% | N/A |
| 2020 | 0.00% | N/A |
| 2019 | 0.00% | -100.00% |
| 2018 | 1.04% | -94.28% |
| 2017 | 18.13% | N/A |
| 2016 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
| 2014 | 0.00% | N/A |
Comparison Apellis Pharmaceuticals (APLS) debt to equity with competitors
Apellis Pharmaceuticals (APLS) debt to equity is 22.59%.